Monkeypox outbreak—Nine states, May 2022: Weekly/June 10, 2022/71 (23); 764–769
PCR testing at CDC on May 18 confirmed that the patient was infected with the West African
clade of Monkeypox virus. Since then, confirmed cases* have been reported by nine states. …
clade of Monkeypox virus. Since then, confirmed cases* have been reported by nine states. …
Antiretroviral adherence level necessary for HIV viral suppression using real-world data
…, R Hazen, H Kirkham, S Suzuki, PG Clay… - JAIDS Journal of …, 2019 - journals.lww.com
Background: A benchmark of near-perfect adherence (≥ 95%) to antiretroviral therapy (ART)
is often cited as necessary for HIV viral suppression. However, given newer, more effective …
is often cited as necessary for HIV viral suppression. However, given newer, more effective …
Influence of application variables on efficacy of glyphosate
DL Jordan, AC York, JL Griffin, PA Clay… - Weed …, 1997 - cambridge.org
Field experiments were conducted from 1993 to 1995 to compare weed control by the
isopropylamine salt of glyphosate at 0.21, 0.42, 0.63, and 0.84 kg ae/ha applied at three stages of …
isopropylamine salt of glyphosate at 0.21, 0.42, 0.63, and 0.84 kg ae/ha applied at three stages of …
Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3 …
…, R Dretler, L Sloan, ST Lewis, PG Clay… - The lancet HIV, 2018 - thelancet.com
Background Doravirine is a novel non-nucleoside reverse transcriptase inhibitor (NNRTI) with
a pharmacokinetic profile supporting once-daily dosing, and potent in-vitro activity against …
a pharmacokinetic profile supporting once-daily dosing, and potent in-vitro activity against …
The abacavir hypersensitivity reaction: a review
PG Clay - Clinical therapeutics, 2002 - Elsevier
Background: Abacavir sulfate is a recent addition to the nucleoside reverse-transcriptase
inhibitor class of antiretroviral agents used in the treatment of HIV infection. It is approved for …
inhibitor class of antiretroviral agents used in the treatment of HIV infection. It is approved for …
Discovery of mutated subnetworks associated with clinical data in cancer
A major goal of cancer sequencing projects is to identify genetic alterations that determine
clinical phenotypes, such as survival time or drug response. Somatic mutations in cancer are …
clinical phenotypes, such as survival time or drug response. Somatic mutations in cancer are …
Complementary and alternative medicine use among Hispanics in the United States
…, KM Shields, KA Clauson, PG Clay - Annals of …, 2007 - journals.sagepub.com
OBJECTIVE: To review the use of complementary and alternative medicine (CAM) in
Hispanics in the US and highlight the modalities most likely to be unfamiliar to healthcare …
Hispanics in the US and highlight the modalities most likely to be unfamiliar to healthcare …
Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 96-week results of a randomised, double-blind, non …
…, R Dretler, CJ Bettacchi, J Sims, PG Clay… - The lancet HIV, 2020 - thelancet.com
Background Doravirine is a novel, non-nucleoside reverse transcriptase inhibitor that has
shown non-inferior efficacy to ritonavir-boosted darunavir, with a superior lipid profile, in adults …
shown non-inferior efficacy to ritonavir-boosted darunavir, with a superior lipid profile, in adults …
Within-host priority effects systematically alter pathogen coexistence
PA Clay, K Dhir, VHW Rudolf… - The American …, 2019 - journals.uchicago.edu
Coinfection of host populations alters pathogen prevalence, host mortality, and pathogen
evolution. Because pathogens compete for limiting resources, whether multiple pathogens can …
evolution. Because pathogens compete for limiting resources, whether multiple pathogens can …
[HTML][HTML] A meta-analysis comparing 48-week treatment outcomes of single and multi-tablet antiretroviral regimens for the treatment of people living with HIV
PG Clay, WC Yuet, CH Moecklinghoff… - AIDS Research and …, 2018 - Springer
Objectives To compare outcomes with single tablet regimens (STR) versus multi-tablet regimens
(MTR) for human immunodeficiency virus (HIV) treatment using published data. Design …
(MTR) for human immunodeficiency virus (HIV) treatment using published data. Design …